Yubo International Biotech Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Yubo International Biotech Limited generated cash of -$1,020,861, which is less than the previous year. Cash used in financing activities reached the amount of $127,164 last year. Net change in cash is therefore -$1,355,007.
Cash Flow
| 2012 | -43K | 0 | 43K |
|---|---|---|---|
| 2013 | -38K | 0 | 43K |
| 2014 | -46K | 0 | 42K |
| 2016 | -56K | 0 | 55K |
| 2018 | -55K | 0 | 56K |
| 2020 | 101.10K | -97.46K | 1.38M |
| 2021 | -1.02M | -564.71K | 127.16K |
YBGJ Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2018 | 2016 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.38M | 1.26K | 1K | 12K | 12K | 7K | 7K |
Operating activities | |||||||
Net income | -1.54M | -711.80K | -144K | -130K | -106K | -103K | -84K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 21.40K | 13.06K | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -159.64K | -2.31K | 0 | 0 | 0 | 0 | 0 |
Inventories | -97.15K | -67.14K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 174.65K | 101.17K | 89K | 74K | 60K | 65K | 0 |
Cash generated by operating activities | -1.02M | 101.10K | -55K | -56K | -46K | -38K | -43K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -564.71K | -97.46K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -564.71K | -97.46K | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||||
Common Stock Issued | 0 | 750K | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 127.16K | 1.38M | 56K | 55K | 42K | 43K | 43K |
Net Change In Cash | -1.35M | 1.38M | 1K | -1K | -4K | 5K | 0 |
Cash at end of period | 27.51K | 1.38M | 2K | 11K | 8K | 12K | 7K |
| Data source | Data source | Data source | Data source | Data source | Data source |